you are viewing a single comment's thread.
I'm thinking there will be quite a lag between initial approval and front-line.Phase I front-line trial is slated to begin in May. Add to that time line phase II and III and we're looking out quite a few years. Then there's the propensity for large institutional shorting weeks after an FDA approval (happens in almost all cases).Still with the pipeline and collaboration $40 may be doable. Of course I hope YOU are right.Shorter term I Like JAZZ.